Zimmer Biomet today said it received FDA 510(k) clearance for its Rosa Partial Knee system for robotically-assisted partial knee replacement surgeries.
Rosa Partial Knee is the latest addition to Zimmer Biomet’s Rosa Robotics platform, which includes the Rosa Knee system for total knee replacement surgery and Rosa One for neurosurgical and spine procedures. The Rosa Partial Knee is also a part of the company’s ZBEdge.
The partial knee system is designed for compatibility with Zimmer Biomet’s Persona Partial Knee. It has 2D and 3D X-Atlas imaging technology with real-time, intraoperative data collection on soft tissue and bone anatomy to improve bone cut accuracy and range of motion gap analysis.
“The FDA clearance of the Rosa Partial Knee system just two years after the introduction of the Rosa Total Knee system builds on the success of our Rosa robotics portfolio, which is designed to help enhance surgical accuracy, precision and efficiency, through the use of intraoperative data that can personalize each procedure. As a result, the Rosa Partial Knee system empowers patients to truly get the knee that’s the best fit for their needs,” COO Ivan Tornos said in a news release.
“The Rosa Partial Knee System is the latest innovative component of ZBEdge, our suite of seamlessly integrated technologies that combines data analytics, robotics, and connected devices and services to inform care decisions. We’re excited about these bold new technologies and the role that Zimmer Biomet can play in reshaping orthopedic procedures and restoring patients’ quality of life.”
